---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-008346"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:32:08.133015+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Baxter explores potential sale of Kidney Care business to private equity; spinoff still possible

## Summary
- Baxter discloses discussions with select private equity investors regarding a potential sale of its Kidney Care business.
- No final decision on separation structure; spinoff remains an option and progress continues.
- Baxter reaffirms commitment to separate Kidney Care business in the second half of 2024.
- The update is provided as Regulation FD disclosure; forward-looking statements caution.

## SEC filing metadata
- accession: 0001628280-24-008346
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828024008346/0001628280-24-008346-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828024008346/bax-20240304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-008346
- JSON: https://secwatch.observer/filing/0001628280-24-008346.json
- Plain text: https://secwatch.observer/filing/0001628280-24-008346.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.